NO165626C - Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol. - Google Patents

Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol.

Info

Publication number
NO165626C
NO165626C NO85854461A NO854461A NO165626C NO 165626 C NO165626 C NO 165626C NO 85854461 A NO85854461 A NO 85854461A NO 854461 A NO854461 A NO 854461A NO 165626 C NO165626 C NO 165626C
Authority
NO
Norway
Prior art keywords
hydrophobic
solublishing
indol
acyl
procedure
Prior art date
Application number
NO85854461A
Other languages
English (en)
Other versions
NO165626B (no
NO854461L (no
Inventor
Jerome Corbiere
Original Assignee
Jerome Corbiere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerome Corbiere filed Critical Jerome Corbiere
Publication of NO854461L publication Critical patent/NO854461L/no
Publication of NO165626B publication Critical patent/NO165626B/no
Publication of NO165626C publication Critical patent/NO165626C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO85854461A 1984-03-14 1985-11-08 Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol. NO165626C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14
PCT/FR1985/000050 WO1985004106A1 (fr) 1984-03-14 1985-03-12 Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues

Publications (3)

Publication Number Publication Date
NO854461L NO854461L (no) 1985-11-08
NO165626B NO165626B (no) 1990-12-03
NO165626C true NO165626C (no) 1991-03-13

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO85854461A NO165626C (no) 1984-03-14 1985-11-08 Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol.

Country Status (12)

Country Link
US (1) US4794117A (no)
EP (1) EP0173729B1 (no)
JP (1) JPS61501566A (no)
KR (1) KR930000029B1 (no)
AT (1) ATE57472T1 (no)
AU (1) AU573321B2 (no)
DE (1) DE3580140D1 (no)
HU (1) HU195918B (no)
IT (1) IT1200410B (no)
NO (1) NO165626C (no)
OA (1) OA08170A (no)
WO (1) WO1985004106A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
NO175404C (no) * 1987-09-11 1994-10-12 Syntex Inc Fremgangsmåte for fremstilling av et öyepreparat og konserveringsmiddelsystem for et slikt preparat
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
WO1991001718A1 (fr) * 1989-08-03 1991-02-21 Eisai Co., Ltd. Procede de photostabilisation pour collyre liquide et collyre liquide photostabilise
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
NZ292690A (en) * 1994-09-01 1998-06-26 Upjohn Co Parenteral formulations comprising a lazaroid steroid, buffer, cosolvent and water
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
BRPI0905707B1 (pt) * 2008-01-18 2024-02-27 Dow Global Technologies Inc Método para aumentar a solubilidade aquosa de um composto ativo e composição compreendendo um composto ativo
KR20110116194A (ko) * 2009-02-03 2011-10-25 선스타 가부시키가이샤 헤스페리딘 함유 조성물
CA2777366C (en) 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CA2805656A1 (en) * 2010-07-21 2012-01-26 Alcon Research, Ltd. Pharmaceutical composition with enhanced solubility characteristics
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
NO165626B (no) 1990-12-03
WO1985004106A1 (fr) 1985-09-26
US4794117A (en) 1988-12-27
IT8519873A0 (it) 1985-03-13
KR850700216A (ko) 1985-12-26
AU573321B2 (en) 1988-06-02
ATE57472T1 (de) 1990-11-15
DE3580140D1 (de) 1990-11-22
EP0173729A1 (fr) 1986-03-12
HUT38263A (en) 1986-05-28
OA08170A (fr) 1987-03-31
KR930000029B1 (ko) 1993-01-06
JPS61501566A (ja) 1986-07-31
HU195918B (en) 1988-08-29
AU4064585A (en) 1985-10-11
NO854461L (no) 1985-11-08
IT1200410B (it) 1989-01-18
EP0173729B1 (fr) 1990-10-17

Similar Documents

Publication Publication Date Title
NO165626C (no) Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol.
DE69211691D1 (de) Pharmazeutische formulierung und pharmazeutisches verfahren
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
FI883249A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
FI894477A0 (fi) Menetelmä terapeuttisesti aktiivisten 7-substituoitujen 3,5-dihydroksihept-6-yynihappojen ja niiden johdannaisten valmistamiseksi ja välituotteina käyttökelpoiset yhdisteet
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
ES2032905T3 (es) Sistema terapeutico transcutaneo.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
SE8602743D0 (sv) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
GR3000838T3 (en) Process for preparing an aquous pharmaceutical solution of an organic acid as the active ingredient
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
ES502654A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
DE3676335D1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
NO900342L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)akridin-7-karboxylsyrer og beslektede forbindelser.
NO832089L (no) Fremgangsmaate ved fremstilling av en terapeutisk virksom metronidazolester
NO175637C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-fluor-3,5-dihydroksykarboksylsyrer og derivater derav
CY1106819T1 (el) Φαρμακα για το ξηρο δερμα
ATE40687T1 (de) Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3375077D1 (en) Galenic form of amitriptyloxide, and process for its preparation
FI885638A0 (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihappomonoesterijohdannaisten valmistamiseksi